Trump Announces Deal With Eli Lilly, Novo Nordisk to Lower Prices on Obesity Drugs

Pure News
844 followers
375 Video Views·Nov 6, 2025
Two world's largest pharmaceutical manufacturers, Eli Lilly and Novo Nordisk, have agreed to offer their most popular GLP-1 weight loss drug.
I call it the Fat Girl, remember?
At drastic discounts, they're very effective drugs.
So far I've never heard anything bad about them. I only hear good about them.
Is there anything bad about them Bob?
Someday maybe it'll come out, which will notify you immediately.
But so far I haven't heard that.
Including the drugs known as Zeppant and Wegovy, often called Ozepic.
It's a triumvirate for American patients that will save lives and improve the health of millions and millions of Americans.
Amazing thing. They are amazing.
I want to thank Eli Lilly, CEO David Ricks, a friend of mine.
We've worked long and hard. He and I got this whole thing started in a way.
And Novo Nordisk CEO Mike Dostar for joining us today.
Great, talented people.
They make a lot of money.
I looked at their money, but they're entitled to their money because the companies have done very well.
Along with Secretary Robert F. Kennedy Jr., Secretary Howard Lutnick.
Do you take any of this stuff, Howard?
Not yet.
Okay, good.
CMS Administrator Mehmet Ayaz. He doesn't take it.
Food and Drug Administrator.
Commissioner Marty McCary.
And Director of Medicare, Chris Plump.
And we have Steve, where's Steve?
Steve, head of public relations for the White House.
He's taking it.
The United States is just 4% of the world's population and consumes only 13% of all prescription drugs.
Yet pharmaceutical companies make 75% of their profits from the American customer.
I would say that's not so good.
To address this chronic unfairness, I signed an executive order earlier this year.
Instructing my administration to do everything in our power to implement most favored nation's drug pricing.
Something that has been helped greatly by tariffs.
Because when nations refuse to do it, we should have put this in the case yesterday.
I just said, well, if you're not going to do it, we're going to charge you a like amount of tariffs.
And they immediately say, we'll do it.
Which means that Americans should pay no more than the lowest price offered anywhere in the world.
So that you've heard for years the disparity where you'll pay $150 for a pill in New York.
And you'll pay $10 for a pill in London.
Now you're going to pay $20 both.
Because the world is a little bit bigger than the U.S., so it goes up that way.
But you'll pay $20 and $20.
A tremendous advantage to our country.
After years of being abused by the world system.
Already Pfizer, AstraZeneca, and EMD in Toronto have agreed to drastically lower their prices for American patients.
And today, Eli Lilly and Novo Nordisk are joining the phenomenal list of the most exciting announcements.
I mean, nobody has ever had announcements like this.
And this has to do with other pharmaceutical products also.
But we're covering this today because it's such a big seller.
I guess it's the number one selling thing there is today.
These are two companies that are behind the groundbreaking weight loss drugs that have helped millions of Americans struggling with obesity.
Live better, longer lives, everything else.
These are the two companies that really broke ground.
Until now, neither of these two popular drugs have been covered by Medicare for weight loss.
And they've only rarely been covered by Medicaid.
They've often cost consumers more than $1,000 per month, and some a lot more than that.
Americans have been spending as much as 520 percent more for Zep Bound and 1,400 percent more for Wegovy than patients in Europe.
Think of that. 1,400 percent more than a patient in Europe for the exact same box.
And that ends starting today.
The other countries are not happy with us.
I don't think they like me too much, Bobby, but it's okay.
Eli Lilly and Novo Nordisk are committing to offer Zep Bound and Wegovy at most favored nations rates for American patients.
This will slash the cost of Wegovy from $1,350 a month to ultimately $250 a month.
$1,350 to $250.
Did I do a good job?
They don't write about it, you know.
They like to not write these things.
And reduce, do you think anybody, do you think Biden could have done this?
I don't think so.
And reduce the monthly cost of Zep Bound from $1,080 to $346.
In addition, they're both committing that future GLP-1 weight loss drugs taken orally, which are currently under development, will be sold at no more than $149 per month.
It's a massive thing of that.
You go from $1,300 to $149 a month.
We anticipate these new versions will be coming out in a very short period of time.
All of these drugs will be available directly to the consumer at TrumpRx.gov.
Trump, they want you to use my name.
Trump, it better be good.
TrumpRx.gov.
And I think it's turning out to be pretty amazing.
Right, guys?
Just as significantly, Medicare and Medicaid will finally cover the cost of these weight loss drugs for millions of patients suffering from obesity.
Co-pays for Medicare patients will be as low as $50.
This is tremendous savings.
I mean, now you're talking about from $1,350 to $50.
This is tremendous news for the American seniors.
And you all remember when I had one-eighth of 1 percent for the year.
I cut it.
One-eighth.
And I was so thrilled.
But now we're cutting it 1,000 percent, 1,200 percent.
Nobody's ever said anything like this.
Nobody else could have done it, but I say that modestly.
In addition, you think it was easy dealing with these people?
It wasn't.
You think it was easy saying, you drug Mr. Eli Lilly that we're selling for $1,300 is going to be sold for $250.
You know the amazing thing?
The stocks all went up.
I mean, these guys are fantastic.
Because it's going to equalize the world.
The world is a bigger place.
And it's going to equalize.
I was a little surprised to see that, but I'm happy about it.
In addition, Eli Lilly and Novo Nordisk have agreed to provide all of their other medications to Medicaid at most favored nations prices.
Most favored nations, meaning that you will pay the lowest price anywhere in the world.
That's what you're going to pay.
Whereas before, they paid low prices and we paid, you know, thousands of percentile ahead more.
And to sell these drugs to all consumers at deeply discounted prices via trumprx.com.
When is trumprx.com opening?
The site is open.
It will launch in terms of giving people prices before the end of the year.
Got to make sure it's successful.
It's got my name on it.
I don't want to be like so many others.
I don't want to be like the train they're building in California.
Okay?
Which has about 15,000 percent cost overrun.
Or for the Obama, the beautiful Obama building that he's building in Chicago for the museum.
Which is now shut it up and dead.
They got it up and they couldn't finish.
It's about, what did you say, five years behind schedule?
About 2,000 percent over budget.
Then he tells us how to run Medicaid.
Many of the most widely used drugs will be available for 60 percent off.
Or even more than that.
In addition, all new medications introduced by Eli Lilly and Novo Nordisk to the American market
will be sold at the heavily reduced most favored nation's price.
Most favored nation's price, that's the best.
Because they have been thousands of percent lower than what we were selling in many cases.
Furthermore, Eli Lilly is investing $27 billion.
That's all.
And Novo Nordisk will invest $10 billion.
That's all.
That's peanuts.
In the United States to reshore, do a big domestic manufacturing job in the facilities.
They're going to spend, so Eli Lilly will spend $27 billion.
Novo is spending $10 billion in the United States.
So they're building new plant and equipment.
That's part of what will be $20 or $21 trillion this year.
There's never been anything like it.
I know nobody talks about it.
But there's never been anything like I would say you would say.
There's never been anything like this.
Whether it's China or Europe or you could take all of Europe,
there's never been anything like this.
So we're already past $17 trillion.
We're going to be, I think by the time the year closes out,
we'll have investments of over $21 trillion based on the way we're going.
And by the way, tariffs are very important.
Without tariffs, perhaps it could be a little bit different, to put it mildly.
Tariffs are so important.
The decision in the Supreme Court would be devastating to our country
if we got a negative, devastating if we got a negative decision.
But this is a great day for American health and healthcare
and for all of the American patients.
These are things that are miracles to have this happen.
And they're, you know, we're bringing all our medicines again because of tariffs.
We're bringing all our medicines.
If you remember where, during COVID, we made almost no medicine here.
We had to go to China.
We had to go to Ireland.
We had to go to other places, UK, to get our medicine.
We didn't make it here.
Now we're making it.
We'll soon be making it all here, again, because of tariffs and my election,
but because of tariffs much more.
For years, politicians have talked about making healthcare affordable,
but my administration is actually doing it.
Americans deserve the best healthcare in the world,
and we're now getting the best healthcare at the lowest price.
So I'd like to ask somebody who's doing a fantastic job,
Secretary Kennedy, to say a few words, followed by Dr. Raj, Dr. Klopp,
and then Eli Lilly, CEO David Ricks, and Novo Nordisk CEO Mike Dostar.
These are incredible stars in that business.
Mike Dostar is a big star.
And I can tell you that David Ricks is one of the hottest people in the world in business,
but the business that he's in is pharmaceutical.
The job he's done with Eli Lilly is incredible.
Both of these gentlemen, they really are stars in the truest sense.
And it's an honor to have you in the White House.
